Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults

Condition:   Chikungunya Virus Infection Intervention:   Biological: Biological Vaccine VLA1553 Sponsor:   Valneva Austria GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials